Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study

Scandinavian Journal of Urology and Nephrology

Volumn 45, Issue 5, 2011, Pages 365-370

  Khajehdehi, Parviz ^a   Pakfetrat, Maryam ^a   Javidnia, Katayoun ^b   Azad, Fariborz ^a   Malekmakan, Leila ^c   Nasab, Mahshid Hashemi ^a   Dehghanzadeh, Gholamreza ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetic nephropathy; IL 8; proteinuria; TGF ; turmeric

Indexed keywords

INTERLEUKIN 8; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TURMERIC;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION; URINARY EXCRETION;

ADMINISTRATION, ORAL; CURCUMA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; PHYTOTHERAPY; PROTEINURIA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054052195     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2011.585622     Document Type: Article

References (27)

1. American Diabetes Association. Diabetic nephropathy. Diabetes Care 1998;21(Suppl):S50-3.
2. Ruggenenti P, Remuzzi G. Nephropathy of type-2 diabetes mellitus. J Am Soc Nephrol 1998;9:2157-69. (Pubitemid 28482168)
3. Ritz E. Nephropathy in type 2 diabetes. J Intern Med 1999; 245:111-26. (Pubitemid 29089108)
4. Deferrari G, Repetto M, Calvi C, Ciabattoni M, Rossi C, Robaudo C. Diabetic nephropathy: From micro- to macroalbuminuria. Nephrol Dial Transplant 1998;24:423-37.
5. Mogenesen CE. Preventing end-stage renal disease. Diabet Med 1998;15(Suppl 4):551-6.
6. Jerums G. Differences in renal outcomes with ACE inhibitors in type 2 diabetic patients: Possible explanations. Miner Electrolyte Metab 1998;24:423-37. (Pubitemid 29056253)
7. Pantsulaia T. Role of TGF-beta in pathogenesis of diabetic nephropathy. 1. Georgian Med News 2006;131: 13-18.
8. Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-beta in kidney diseases. Am J Physiol 1994; 266:F829-42.
9. Goldfarb S, Ziyadeh FN. TGF-beta: A crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc 2001;112:27-32; discussion 33.
10. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, et al. Association of urinary markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 2008;19:789-97.
11. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, et al. Serum concentrations of markers of TNF-a and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Soc Nephrol 2009;4:62-70.
12. Ahlwalia TS, Khuflar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, et al. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PloS ONE 2009;4: E5168.
13. Shama S, Kulkarni SK, Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Physiol 2006;33:940-5. (Pubitemid 44427317)
14. Suresh Babu P, Srinivasan K. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozocin diabetic rats. Mol Cell Biochem 1998;181:87-96. (Pubitemid 28127781)
15. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 2001;131:2090-5. (Pubitemid 32720635)
16. Gaedeke J, Noble NA, Border WA. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 2004;66:112-20. (Pubitemid 38870087)
17. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: Impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 2002;95:1206-14. (Pubitemid 35013053)
18. Kim YS, Ahn Y, Hong MH, Joo SY, Kim KH, Sohn IS, et al. Curcumin attenuates inflammatory responses of TNF-alpha- stimulated human endothelial cells. J Cardiovasc Pharmacol 2007;50:41-9. (Pubitemid 47220445)
19. Lao CD, Ruffin MT IV, Normolie D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;17:6-10.
20. He X-G, Lin L-Z, Lian L-Z, Lindenmaier M. Liquid chromatography- electrospray mass spectrometric analysis of curcuminoids and sesquiterpenoids in turmeric (Curcuma longa). J Chromatogr A 1998;818:127-32. (Pubitemid 28401441)
21. Remuzzi M, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-56. (Pubitemid 28516069)
22. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease study. Ann Intern Med 1995;123:754-62.
23. GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologial). Randomized placebo-controlled trial of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-63.
24. Fioretto P, Sutherland DE, Najafian S, Mauer M. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int 2006;69:907-12; discussion 33.
25. Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in stretozotocin diabetic rats. Br J Pharmacol 2001;133:687-94. (Pubitemid 32642874)
26. Hashem RM, Soliman HM, Shaapan SF. Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. J Pharm Pharmacol 2008;60:83-9.
27. Aydin M, Ozkok E, Ozturk O, Agachan B, Yilmaz H, Yaylim I, et al. Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients. Exp Clin Transplant 2007;5:610-13. (Pubitemid 47261591)